Trial of Intravenous Alteplase before Endovascular Treatment for Stroke. Reply

N Engl J Med. 2022 Feb 3;386(5):496-497. doi: 10.1056/NEJMc2119227.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Administration, Intravenous
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Stroke* / drug therapy
  • Tissue Plasminogen Activator* / therapeutic use

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator